Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Synergy Rx vs Vytora Health

Synergy Rx
Graded #41

Higher grade

vs+3.9000000000000057
Vytora Health
Graded #79

Lower grade

The verdict

Synergy Rx takes it — 76.2/100 to 72.3/100.

Synergy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock clinical contact.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSynergy Rx +3
62
59
Dose & formulationSynergy Rx +3
88
85
Clinical oversightVytora Health +4
92
96
Labs & monitoringSynergy Rx +11
66
55
FulfillmentVytora Health +18
78
96
Contract termsSynergy Rx +48
68
20
Synergy Rx · left barVytora Health · right bar

The numbers

MetricSynergy RxVytora Health
WeighScore76.2/10072.3/100
GradeCC
Scorecard rank#41#79
SemaglutideFrom $199/mo$180/mo (all doses, compounded)
TirzepatideFrom $349/mo$249/mo (all doses, compounded)
CoverageNot disclosedAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Synergy Rx

Graded #41 · C

Strengths

  • Prescribes FDA-approved brand Wegovy, Ozempic and Mounjaro when clinically appropriate
  • Unlimited appointments, unlimited messaging and 24/7 access to a dedicated clinical team
  • $100 welcome credit at checkout, and FSA/HSA eligible

Where it loses points

  • Publishes no GLP-1 price anywhere on its own site
  • At $349/mo tirzepatide sits roughly $100 above the compounded median we track
  • Does not publish which states it serves
  • No published cancellation or refund terms
Vytora Health

Graded #79 · C

Strengths

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

Where it loses points

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard